Altimmune plans Phase 2 trials in 2025 for pemvidutide in alcohol use disorder and liver disease, highlighting weight loss ...

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...

综合研究结论和讨论部分，该研究揭示了在小鼠模型中，大脑小胶质细胞数量和激活状态受酒精饮用和应激的影响存在性别差异，且这些影响具有区域特异性和时间依赖性。在杏仁核中，EtOH 早期对小胶质细胞有抑制作用，但长期暴露后效果会逆转。在海马体中，EtOH 对小胶质细胞的影响随时间和区域变化而不同，同时应激对小胶质细胞表型的影响主要集中在海马体，且存在性别特异性。这些发现表明，简单地将小胶质细胞分类为 M1 ...

Semaglutide shows promise in reducing alcohol cravings and consumption. Could it be a future treatment for AUD?

EUR/AUD slipped lower on Friday as uncertainty sparked by U.S. President Donald Trumps tariff war negatively impacted ...

Alcohol addiction devastates millions of lives each year, tearing apart families and leaving lasting scars. Yet, amid the struggle to curb its grip, a breakthrough may be on the horizon. Scientists ...

If you answered yes to any of these, then you might have alcohol use disorder, or AUD. Ailsa Frank, an alcohol reduction hypnotherapist specialist and founder of the Feel Amazing hypnotherapy ...

EUR/AUD eased slightly on Thursday as another round of tariff threats and uncertainty surrounding the proposed Ukraine ...

A groundbreaking study from TrimBody MD has revealed that semaglutide, a GLP-1 agonist originally designed for diabetes and ...

Semaglutide may help reduce alcohol cravings and intake, according to a clinical trial. Participants receiving the drug drank ...

Evercore ISI likes the expansion of pemvidutide into alcohol liver disease and alcohol use disorder as it adds another leg to the pemvidutide ...

In comparison to 2016-2017 estimates, alcohol-related liver disease has increased to 29% in 2020 in the US. Although many adults meet the criteria for AUD, only a few receive treatment or ...